blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1075471

EP1075471 - INDOLYL DERIVATIVES AS SEROTONERGIC AGENTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  23.09.2005
Database last updated on 03.10.2024
Most recent event   Tooltip23.09.2005No opposition filed within time limitpublished on 09.11.2005  [2005/45]
Applicant(s)For all designated states
Wyeth
Five Giralda Farms
Madison, NJ 07940-0874 / US
[N/P]
Former [2002/25]For all designated states
Wyeth
Five Giralda Farms
Madison, New Jersey 07940-0874 / US
Former [2001/07]For all designated states
AMERICAN HOME PRODUCTS CORPORATION
Five Giralda Farms
Madison, New Jersey 07940-0874 / US
Inventor(s)01 / KELLY, Michael, Gerard
19 Clinton Court
Plainsboro, NJ 08536 / US
02 / KANG, Young, Hee
324 Andover Place
Robbinsville, NJ 08691 / US
 [2001/07]
Representative(s)Connelly, Michael John, et al
C/o Patent Department Wyeth Laboratories Huntercombe Lane South Taplow
Maidenhead Berkshire SL6 0PH / GB
[N/P]
Former [2001/07]Connelly, Michael John, et al
c/o Patent Department Wyeth Laboratories Huntercombe Lane South Taplow
Maidenhead Berkshire SL6 0PH / GB
Application number, filing date99918860.028.04.1999
[2001/07]
WO1999US09129
Priority number, dateUS1998006904529.04.1998         Original published format: US 69045
[2001/07]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9955694
Date:04.11.1999
Language:EN
[1999/44]
Type: A1 Application with search report 
No.:EP1075471
Date:14.02.2001
Language:EN
The application published by WIPO in one of the EPO official languages on 04.11.1999 takes the place of the publication of the European patent application.
[2001/07]
Type: B1 Patent specification 
No.:EP1075471
Date:17.11.2004
Language:EN
[2004/47]
Search report(s)International search report - published on:EP04.11.1999
ClassificationIPC:C07D401/06, A61K31/445
[2001/07]
CPC:
C07D401/14 (EP); A61P15/10 (EP); A61P25/22 (EP);
A61P25/24 (EP); A61P25/30 (EP); A61P43/00 (EP);
C07D209/08 (EP) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [2001/07]
Extension statesAL02.10.2000
LT02.10.2000
LV02.10.2000
RO02.10.2000
SI02.10.2000
TitleGerman:INDOLDERIVATE ALS SEROTONERGISCHE MITTEL[2001/07]
English:INDOLYL DERIVATIVES AS SEROTONERGIC AGENTS[2001/07]
French:DERIVES D'INDOLYLE UTILISES COMME AGENTS SEROTONINERGIQUES[2001/07]
Entry into regional phase02.10.2000National basic fee paid 
02.10.2000Designation fee(s) paid 
02.10.2000Examination fee paid 
Examination procedure05.11.1999Request for preliminary examination filed
International Preliminary Examining Authority: EP
02.10.2000Examination requested  [2001/07]
15.01.2003Despatch of a communication from the examining division (Time limit: M06)
22.07.2003Reply to a communication from the examining division
19.08.2003Despatch of a communication from the examining division (Time limit: M06)
17.02.2004Reply to a communication from the examining division
01.04.2004Communication of intention to grant the patent
14.09.2004Fee for grant paid
14.09.2004Fee for publishing/printing paid
Opposition(s)18.08.2005No opposition filed within time limit [2005/45]
Fees paidRenewal fee
09.04.2001Renewal fee patent year 03
08.04.2002Renewal fee patent year 04
07.04.2003Renewal fee patent year 05
06.04.2004Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]WO9533721  (LUNDBECK & CO AS H [DK], et al) [Y] 1-15 * pages 37-39; claim 1 *;
 [Y]WO9623784  (JANSSEN PHARMACEUTICA NV [BE], et al) [Y] 1-15 * pages 18-19; table 4 *;
 [PY]WO9828293  (LUNDBECK & CO AS H [DK], et al) [PY] 1-15 * page 4 *;
 [DA]  - K. FRETER ET AL., "4-(indolyl-3)-1-(benzimidazolonylalkyl)-piperidines, a novel group of potential antiallergy compounds", ARZNEIM.-FORSCH./DRUG RES., (1985), vol. 35, no. 1, pages 272 - 276, XP002111572 [DA] 1-15 * example 9 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.